Company Overview of Canaccord Genuity Inc.
Canaccord Genuity Inc. is an investment banking firm that provides financial advisory services. The firm offers mergers and acquisitions advisory, divestitures, recapitalizations, valuations, fairness opinions, private placements, private capital raising, and valuation analysis services. Additionally, it provides underwriting, Initial Public Offering (IPO), and equity sales and trading services. The firm caters to metals and mining, energy, technology, telecommunications, life sciences, real estate, and aerospace industries. Canaccord Adams, formerly known as Adams Harkness, Inc., was founded in 1969 and is based in Boston, Massachusetts with additional offices across the United States. Cana...
99 High Street
Boston, MA 02110
Founded in 1969
Key Executives for Canaccord Genuity Inc.
Chief Financial Officer and Treasurer
Compensation as of Fiscal Year 2014.
Canaccord Genuity Inc. Key Developments
Marko Kozul Agrees to Join Canaccord Genuity's Equity Research Team as a Managing Director Covering Biotechnology Companies
Jul 31 14
Canaccord Genuity announced that Marko Kozul, M.D. has agreed to join its Equity Research team as a Managing Director covering biotechnology companies. Based in the firm's San Francisco office, Dr. Kozul will focus on companies with advanced biotechnology platforms in the areas of neurology, immunology, obesity, oncology, and orphan infectious diseases. He joins senior Healthcare analysts John Newman and Corey Davis, building upon the firm's existing US life science practice. Dr. Kozul joins Canaccord Genuity from Leerink Partners where he served as a senior biotechnology analyst and was previously analyst at ThinkEquity Partners and Jefferies & Company.
Canaccord Genuity Inc. Presents at 2014 Bioshares Biotech Summit, Jul-18-2014 05:20 PM
Jun 23 14
Canaccord Genuity Inc. Presents at 2014 Bioshares Biotech Summit, Jul-18-2014 05:20 PM. Venue: Rydges Lakeland Resort, Queenstown, New Zealand. Speakers: Matthijs Smith, Healthcare Analyst.
Canaccord Genuity Hires Corey Davis as Managing Director
Jun 5 14
Canaccord Genuity announced the expansion of its Healthcare Equity Research team with the hiring of Corey Davis, Ph.D., as a Managing Director covering Specialty Pharmaceuticals, with a focus in certain therapeutics areas within the biotech sector. Mr. Davis brings over 16 years of sell-side experience covering Specialty Pharmaceuticals companies, most of those years at JP Morgan and at Jefferies. He is widely recognized for his expertise on a broad range of key issues within the industry, including IP law, CNS-related disorders, clinical trial design, financial modelling, and has deep relationships with thought leaders in the industry. At Canaccord Genuity, Corey will establish strong coverage of key Specialty Pharmaceuticals names, as well as a series of later-stage biopharmaceutical companies that offer investors a broad range of investment opportunities in drug development.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|